Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Endocrinology Endocrinology for January/February 2020 Zoledronate Promotes Postdenosumab Bone Retention, Anorexia Linked to Low Bone Density, Osteoporosis, More must reads Endocrinology for November/December 2019 Vitamin D Alone Does Not Reduce Fracture Risk, Osteoporotic Fracture Risk is Undermanaged in Older Adults, Reward, decision-making brain regions altered in teens with obesity, Nearly one in five U.S. adolescents have prediabetes, Findings confirm link between methimazole and risk for acute pancreatitis, More must readsEndocrinology for September/October 2019 Multiple Zoledronic Acid Doses May Be Needed After Stopping Denosumab, Romosozumab Benefits Osteoporosis Patients Regardless of Renal Insufficiency, Osteoporosis Remains a Costly Burden to Older US Adults, Certain diabetes drugs may thwart dementia, Vitamin D Does Not Improve Bone Density, Structure in Healthy Patients, More must readsEndocrinology for July/August 2019 Inadequate Glycemic Control in Type 1 Diabetes Leads to Increased Fracture Risk, Bisphosphonates Before Denosumab May Prevent Postdenosumab BMD Rebound Effect, Once-Weekly Teriparatide Still Achieves Bone Mineral Density Gains, Inadequate glycemic control in type 1 diabetes leads to increased fracture risk, Semen cryopreservation viable for young transgender patients in small study, More must readsEndocrinology for May/June 2019 Younger men and women show similar rates of osteopenia, Subclinical hypothyroidism may be associated with increased cancer risks, More must readsPages« first 1 2 3 4 5 last »
